• Development And Validation Of The Angiotensin-Converting Enzyme Inhibitor (Acei) Induced Angioedema Investigator Rating Scale And Proposed Discharge Criteria

    May 1, 2015, 00:00

  • The effect of Vortioxetine on family functioning in Adults with Major depressive Disorder

    May 1, 2015, 00:00

  • Long-Term outcomes of Hpv Vaccination In Prevention of Anal Cancer In older Hiv-Positive Men Who Have Sex With Men

    May 1, 2015, 00:00

  • Dual versus Triple Therapy for eradication of Helicobacter pylori- an evidence-based meta-analysis of Randomized Clinical trials

    May 1, 2015, 00:00

  • Crowdsourcing Healthcare Technology Innovation- The Use Of Open Competitions To Pursue Novel Healthcare Technology Solutions

    May 1, 2015, 00:00

  • Clinical Outcomes And Treatment Patterns of Venous Thromboembolism Among Cancer Patients In A Large Commercial Database

    May 1, 2015, 00:00

  • Comparison Of Health Technology Assessment (Hta) Rankings By German And French Hta Agencies

    May 1, 2015, 00:00

  • Economic evaluation of a Randomized controlled trial of Pharmacist-Supervized Patient self-testing of Warfarin Therapy

    May 1, 2015, 00:00

  • The Early Impact of Closing The Coverage Gap On Annual Drug Expenditures, Out-of-Pocket Spending, Drug Utilization, And Access To Prescription Among Seniors With Chronic Conditions

    May 1, 2015, 00:00

  • An assessment of the Economic impact of the adoption of a new Mechanical fixation device along with a new skirted intra-peritoneal onlay mesh (IPOM) on Hospital costs of open Ventral Hernia repair Surgeries

    May 1, 2015, 00:00

  • Accumulated one Year Health Utility Loss After Sustaining A Hip Fracture In Mexico

    May 1, 2015, 00:00

  • The financial impact of Blood specimen rejection due to the poor pre-analytical Quality in Healthcare Facility in China

    May 1, 2015, 00:00

  • Recent trends in Urgent Antibacterial Threat-Related Hospitalization In the US

    May 1, 2015, 00:00

  • The Cost effectiveness of a Novel High Priced Combination Therapy for Hepatitis C In Treatment NaÏVe Genotype 1 Infected Patients

    May 1, 2015, 00:00

  • The characteristics of Pharmacy and Therapeutic Committees in Saudi Hospitals

    May 1, 2015, 00:00

  • Recommendations For The Linguistic Validation Of Pediatric Clinical Outcomes Assessments

    May 1, 2015, 00:00

  • Anti-Diabetic Therapies and the risk of acute Pancreatitis- a Nationwide Retrospective cohort study from taiwan

    May 1, 2015, 00:00

  • The Value Adults Place On Child Health And Functional Status

    May 1, 2015, 00:00

  • Principles of policy Framework in the Pharmaceutical wholesale and retail system in lower income European Countries

    May 1, 2015, 00:00

  • Development Of A Disease Model For Sporadic Inclusion Body Myositis (Sibm)

    May 1, 2015, 00:00

  • Economic impact of dapagliflozin vs. Other antidiabetic drugs for the treatment of patients with type 2 diabetes

    May 1, 2015, 00:00

  • Measurement Equivalence And Patient Preference For The Sf-36v2 On A Handheld Device And Smartphone App

    May 1, 2015, 00:00

  • An analysis of recent HTA decisions in Taiwan and Korea- influence from Australia and the UK

    May 1, 2015, 00:00

  • Biologic Brands and Biosimilars for Rheumatoid Arthritis In The Eu5- Contention For Cost-Effectiveness

    May 1, 2015, 00:00

  • Long-Acting Bronchodilators And Risk of Adverse Cardiovascular Events In Chronic Obstructive Pulmonary Disease- A Focused Critical Review

    May 1, 2015, 00:00

  • Cost-effectiveness of stimulation of the Sphenopalatine Ganglion (SPG) for the treatment of Chronic Cluster Headache- a model-based analysis based on the pathway CH-1 study

    May 1, 2015, 00:00

  • Patient reported outcomes in Glaucoma a Systematic review

    May 1, 2015, 00:00

  • Characterization of early stage Breast Cancer patient management in a practice setting with the 21-Gene Breast Cancer assay

    May 1, 2015, 00:00

  • Improved Health status of Haemophilia B Patients treated with Nonacog Beta Pegol, a new Glycopegylated recombinant fix product with Prolonged Half-Life

    May 1, 2015, 00:00

  • Adherence to Liraglutide once daily or exenatide once weekly Over A 12-Month period among Commercially Insured Patients With Type 2 diabetes Mellitus- A retrospective observational study

    May 1, 2015, 00:00

  • Impact Of Medicaid Discontinuity On Health Care Resource Utilization Among Non-Elderly Adults With Cardiovascular Disease

    May 1, 2015, 00:00

  • For Two Companies The Fda Pro Guidance Leads To Similar But Different Measures- A Case Study In Psoriasis

    May 1, 2015, 00:00

  • Can Social Network analysis be used to Identify Doctor Shoppers?

    May 1, 2015, 00:00

  • Response Rates In Direct-To-Patient Surveys

    May 1, 2015, 00:00

  • Modeling the Cost-Effectiveness of Novel Direct Acting Antiviral (DAA) Treatments In Patients Co-Infected with Hepatitis C Virus (Hcv) and Human Immunodeficiency Virus (HIV)

    May 1, 2015, 00:00

  • Self-reported Health status of patients with Chronic Hepatitis B in China

    May 1, 2015, 00:00

  • A descriptive analysis of patient characteristics and health care burden associated with chronic obstructive pulmonary disease in the u.s. Medicare population

    May 1, 2015, 00:00

  • Evaluating Clinical And Economic Outcomes Associated With Liposomal Bupivacaine (LB) For Postsurgical Pain Following Total Knee Arthroplasty (TKA)

    May 1, 2015, 00:00

  • Joint Estimation Of Markov Chain Transition Probabilities Using Survival Models And Constrained Optimization- A Case Study On Diabetes And Mortality And Their Association With Body Mass Index, Age, And Gender

    May 1, 2015, 00:00

  • Clinical and cost outcomes from different Hyaluronic Acid treatments in patients with Knee Osteoarthritis

    May 1, 2015, 00:00

  • Comparative effectiveness, approval Rates and Pricing of Drugs with FDA’s breakthrough Therapy designations

    May 1, 2015, 00:00

  • Healthcare Utilization and costs of Serotonin Syndrome with concomitant use of Serotonergic agents

    May 1, 2015, 00:00

  • Carbohydrate intake and Breast Cancer risk in African American and European American Women in the Women’s circle of Health Study

    May 1, 2015, 00:00

  • Cost-Effectiveness of Treating Advanced Progressive Pancreatic Neuroendocrine Tumor Patients With Everolimus Versus Sunitinib In Sweden

    May 1, 2015, 00:00

  • Meta-Analysis of the Safety of Sipuleucel-T Immunotherapy in Prostate Cancer

    May 1, 2015, 00:00

  • Content Validity Of A Patient-Reported Outcome Instrument For Pancreatic Cancer

    May 1, 2015, 00:00

  • Comparative Persistency with Newer agents used to Treat Type 2 Diabetes (T2dm) In the united states- canagliflozin Versus Dipeptidyl Peptidase-4 (Dpp-4) Inhibitors and Glucagon-Like Peptide-1 (Glp-1) agonists

    May 1, 2015, 00:00

  • Does differential framing of opt-out alternatives in discrete choice experiments (dces) matter? Comparison of random utility maximization (rum) and random regret minimization (rrm) models

    May 1, 2015, 00:00

  • Impact of a Community pharmacy-based transition of care program on Hospital readmissions at 30 and 180 Days

    May 1, 2015, 00:00

  • Feasibility And Acceptability Of Minimal Modeling Value Of Information Analyses For Real-Time Prioritization Decisions Within A Large Cancer Clinical Trials Cooperative Group

    May 1, 2015, 00:00

  • Prevalence and determinants of Low-Cost Generic Drug program use in the privately-insured Adult Population

    May 1, 2015, 00:00

  • Using a treatment transition model to Evaluate the Effects of Neglecting Hba1c Drift In oral anti-diabetic Drugs for Type 2 Diabetes

    May 1, 2015, 00:00

  • Implementation Of The American Diabetes Association’s Standards Of Medical Care- The Case Of Statin Utilization In The Elderly With Diabetes

    May 1, 2015, 00:00

  • Risk Of Diabetes With Or Without The Presence Of Other Obesity-Related Comorbidities (Hypertension, Stroke And Coronary Heart Disease)- National Health And Nutrition Examination Survey, 2007-2010

    May 1, 2015, 00:00

  • Hypofractioned Radiotherapy In the Treatment of Early Breast Cancer- Systematic Review And Meta-Analysis

    May 1, 2015, 00:00

  • Cardiovascular Safety With The Concurrent Use Of Mood Stabilizers Or Atypical Antipsychotics And Stimulants In Children And Adolescents With Attention Deficit/Hyperactivity Disorder And Bipolar Disorder

    May 1, 2015, 00:00

  • Use of real World evidence in German amnog applications

    May 1, 2015, 00:00

  • Patient Self-Assessments in advanced Parkinson’s Disease within updrs and “off” time Subgroups- Comparison of Ipx066 With Immediate-Release Carbidopa-Levodopa

    May 1, 2015, 00:00

  • Bayesian Network Meta-Analysis (Nma) to Assess Relative Efficacy of Canagliflozin (Cana) Versus Glucagon-Like Peptide-1 (Glp-1) Agonists in Dual and Triple Therapy In Patients with type 2 Diabetes Mellitus (T2dm)

    May 1, 2015, 00:00

  • Direct cost of Hypothyroidism and its complications in Ukraine

    May 1, 2015, 00:00

  • Healthcare resource Utilization and costs associated with Paliperidone Palmitate versus oral Atypical Antipsychotics among patients with Schizoaffective Disorder

    May 1, 2015, 00:00

  • Tracking Healthcare Utilization (Cost) In Pseudobulbar affect Patients treated with Nuedexta

    May 1, 2015, 00:00

  • Comparative effectiveness of Bimatoprost 0.03%/Timolol 0.5% preservative-free fixed combination for the treatment of open-angle Glaucoma and OHT; interpreting results from a large treatment Network

    May 1, 2015, 00:00

  • Economic impact derived from the use of a catheter impregnated with Antibiotic in pediatric patients with hydrocephalus treated with external shunts in Mexico

    May 1, 2015, 00:00

  • Cost effectiveness analysis of different treatment alternatives in Children with attention deficit hyper activity Disorder (ADHD)

    May 1, 2015, 00:00

  • Review Of Caregiver Burden Scales For Patients With Visual Impairement In Japan

    May 1, 2015, 00:00

  • Is Pharmaceutical care effective for Improving Blood Pressure Control and medication adherence among Hypertensive Patients? a review

    May 1, 2015, 00:00

  • Describing Treatment Patterns In Adolescents And Adults With Allergic Asthma

    May 1, 2015, 00:00

  • A Conservative Approach To Assess Warfarin Time-In-Therapeutic Ranges Among Nonvalvular Atrial Fibrillation Patients In An Integrated Healthcare Delivery System Setting In The U.S

    May 1, 2015, 00:00

  • Factors affecting Health-related Quality of life in individuals with Depression

    May 1, 2015, 00:00

  • Regional variation in Catastrophic Health Care spending in Pakistan

    May 1, 2015, 00:00

  • Economic Burden Of Antibody Mediated Rejection Following Kidney Transplantation- Comparative Analysis Using The Premier Hospital Database

    May 1, 2015, 00:00

  • Validation Of A Syndrome-Specific Instrument To Assess Angina Treated By Traditional Chinese Medicine (Tcm-Saq)- The Ability To Detect Change

    May 1, 2015, 00:00

  • A Multivariate analysis of Prescribing Information for Next Generation type 2 Diabetes treatments

    May 1, 2015, 00:00

  • What cost-effectiveness demands and market access challenges will novel antibiotics for mdr gnps approved via the streamlined lpad pathway face?

    May 1, 2015, 00:00

  • Long-Term Health Care Costs Among Adults With Type 2 Diabetes Initiating Dpp-4 Inhibitors

    May 1, 2015, 00:00

  • Patient Benefit-Risk Preference of Insulin treatment- an Examination of Health Literacy- and Beliefs As Predictors of Preference and Risk Aversion

    May 1, 2015, 00:00

  • Examining risk factors and predicting readmissions in COPD patients

    May 1, 2015, 00:00

  • Assessment Of Payer Willingess To Pay For Novel Heart Failure Therapies- Incremental Improvement In Symptom Relief Versus Disease Modifying

    May 1, 2015, 00:00

  • Bibliometric analysis of the Worlwide Scientific Production of Oral Health

    May 1, 2015, 00:00

  • Health Data Entanglement And Artificial Intelligence-Based Analyses To Improve The Effectiveness Of Services And Tackle The Healthcare Spending Growth

    May 1, 2015, 00:00

  • Concomitant Sleep Disorder Significantly Enhances The Risk Of Cardiovascular Disease In Patients With Psoriasis

    May 1, 2015, 00:00

  • Review of cost-effectiveness analyses of varicella vaccination- which model structure assumptions and input parameters matter?

    May 1, 2015, 00:00

  • Quality of Life Domains Associated With Readmission

    May 1, 2015, 00:00

  • Prioritization of Comparative Effectiveness Research Questions Based On Identification of The Most Relevant Outcomes To Improve Clinical Practi An Application of Mcda To Dialysis Research Planning

    May 1, 2015, 00:00

  • Outcomes-Based Pricing And Reimbursement Arrangements For Pharmaceutical Products In The Us And Eu-5- Payer And Manufacturer Experience And Outlook

    May 1, 2015, 00:00

  • A Large-Scale Cross-Sectional Study of Hiv Infection among Male Clients over 50 years old in low-cost commercial sex venues of Guangxi,China

    May 1, 2015, 00:00

  • Comparison of Disease Status and Outcomes of Patients With Rheumatoid Arthritis (Ra) Receiving Adalimumab or Etanercept Monotherapy In The United States (Us)

    May 1, 2015, 00:00

  • Cluster Analysis Of Healthcare Costs Patterns In END STAGE Renal Failure Patients Who Initiated Hemodialysis

    May 1, 2015, 00:00

  • Association of Obesity with 30-day readmission rates among patients Hospitalized with Acute Bacterial Skin and Skin-Structure Infections (ABSSSI)

    May 1, 2015, 00:00

  • The Emerging Role Of Patient-Reported Outcomes (Pros) In Fda Hematology And Oncology Product Labels

    May 1, 2015, 00:00

  • Population Based Valuation Of Private Annuity And Life Insurances Under Taiwan’s National Health Insurance System

    May 1, 2015, 00:00

  • Exploratory Psychometric Analysis of The Eq-5d In A Myelofibrosis Population

    May 1, 2015, 00:00

  • Prevalence of self-reported Adult ADHD Symptoms among University Students- a Multidisciplinary Comparison

    May 1, 2015, 00:00

  • Review of Disease Burden of Lung Cancer In China’s Beijing And Shanghai

    May 1, 2015, 00:00

  • Liraglutide vs. Sitagliptin as add-on to metformin treatment for type 2 diabetes mellitus- short term cost-per-controlled patient in italy

    May 1, 2015, 00:00

  • The impact of NCMS policies on inpatient Health Expenditure and its equality in Rural China

    May 1, 2015, 00:00

  • Association of change in forced vital capacity with Healthcare resource Utilization in patients with Newly Diagnosed Idiopathic Pulmonary Fibrosis

    May 1, 2015, 00:00

  • Long-term cost per sustained virologic response in patients with Genotype 1 Chronic Hepatitis C virus treated with Viekira Pak +/- Ribavirin and standard of care in the US

    May 1, 2015, 00:00

  • Association Between Sedative-Hypnotics Use and Falls In Community-Dwelling Older Adults

    May 1, 2015, 00:00

  • Does Azilsartan Medoximil – Chlorthalidone Lower Risk of Coronary Heart Disease Than Olmesartan Medoximil – Hydrochlorthiazide In Patients With Essential Hypertension- A Cost-Effective Analysis

    May 1, 2015, 00:00

  • The Impact Of Stroke Centers On The Length Of Stay Among Ischechemic Stroke Patients In Alberta

    May 1, 2015, 00:00

  • A Novel Conceptual model of Cystic Fibrosis Based on Qualitative Patient Research

    May 1, 2015, 00:00

  • A Review Of The Effectiveness Of Visual Medication Tools In Boosting Patient Adherence And Reducing Hospital Admissions

    May 1, 2015, 00:00

  • Impact of Kentucky House bill 1 on concurrent prescribing of Opioid, Alprazolam, and Carisoprodol

    May 1, 2015, 00:00

  • Add Back Therapy Use Among Endometriosis Patients Initiating Leuprolide Acetate (La) Therapy- Association With Improved Adherence And Lower Surgery Rates In A Cohort Of Commercially Insured Women

    May 1, 2015, 00:00

  • Comparing the Healthcare Utilization and costs of early- and late-stage Alzheimer’s disease Patients residing in long-term care facilities

    May 1, 2015, 00:00

  • Comprehensive Assessment Of Patient Adherence To Drug Therapy- An Example Utilizing Real World Data For An Oral Multiple Sclerosis Treatment

    May 1, 2015, 00:00

  • User experience a novel, but critical element in payer and purchaser value analysis of medical Technologies

    May 1, 2015, 00:00

  • PREVALENCE AND DIRECT MEDICAL COSTS ASSOCIATED WITH ANGINA AND CHEST PAIN FOLLOWING PERCUTANEOUS CORONARY INTERVENTION IN THE UNITED STATES

    May 1, 2015, 00:00

  • DEVELOPMENT AND VALIDATION OF ALGORITHMS TO IDENTIFY STATIN INTOLERANCE IN A US ADMINISTRATIVE DATABASE

    May 1, 2015, 00:00

  • Assessing the impact of increased maintenance dosing of Adalimumab and Etanercept on managed care costs

    May 1, 2015, 00:00

  • Cost-Effectiveness of Cetuximab+folfiri Versus Bevacizumab+Folfiri at the Public Healthcare System In Brazil €“ The Fire 3 Trial Economic Perspective

    May 1, 2015, 00:00

  • Lack Of Adherence To Immunosuppressive Treatment In Kidney Transplant Patients- Estimation Of Associated Health Resource Utilization

    May 1, 2015, 00:00

  • A Novel Measure To Assess Self-Reported Physical Functioning In Patients With Sporadic Inclusion Body Myositis (Sibm)

    May 1, 2015, 00:00

  • Incidence of Polypharmacy among emergency patients at a tertiary care Hospital in Karachi- an ignored paradigm for Quality Drug Therapy

    May 1, 2015, 00:00

  • Fractional flow reserve versus Coronary Angiography guided management in non-st elevation myocardial infarction- a Health economic analysis

    May 1, 2015, 00:00

  • comparing Medical Therapies For Heavy Menstrual Bleeding Related To Uterine Fibroids

    May 1, 2015, 00:00

  • The Use Of Antibiotics Prophylaxis For Intrathecal Baclofen Pump Placement In Pediatrics Patients

    May 1, 2015, 00:00

  • Measuring Upper Limb Function In Multiple Sclerosis- Enhancing The Abilhand’s Performance

    May 1, 2015, 00:00

  • Teriflunomide Shows Consistent Clinical Efficacy On Severe Relapses Across temso and tower- 2 Phase 3 trials

    May 1, 2015, 00:00

  • Expected costs and Health outcomes for a Cohort of Albertans diagnosed with Hepatitis C

    May 1, 2015, 00:00

  • An evaluation of clinical remission and safety among Biologics for moderate-to-severe crohns disease- a Bayesian Network meta-analysis

    May 1, 2015, 00:00

  • Definition of end-of-life period and Quality Benchmarks in Terminal Cancer Care- a Literature Review

    May 1, 2015, 00:00

  • Evaluating the outcomes of a High-Risk medication intervention Program between dual and non-dual eligible Medicare advantage Beneficiaries

    May 1, 2015, 00:00

  • Comparative Effectiveness of Clostridial collagenase ointment for the treatment of Venous Leg Ulcers In outpatient Care Settings

    May 1, 2015, 00:00

  • Economic Burden of Hyperphosphatemia In Chronic Kidney Disease In China- A Review

    May 1, 2015, 00:00

  • Commercial health insurance – a new power to push china healthcare reform forward?

    May 1, 2015, 00:00

  • Depression Treatment Among Women With Cardio-Metabolic Conditions- Findings From Medical Expenditure Panel Survey 2012

    May 1, 2015, 00:00

  • Validation Of A Vitality Quotient To Measure The Effect Of Food Supplements On Fatigue In Healthy Subjects

    May 1, 2015, 00:00

  • Bevacizumab for front-Line Treatment of Epithelial Ovarian, Fallopian tube or Primary Peritoneal Cancer Patients With High Risk of Relapse- a Cost Effective option for Canadian Patients

    May 1, 2015, 00:00

  • The impact of anxiety on Healthcare Utilization and costs among respondents from the Co-Morbidities and Symptoms of depression (CODE) study

    May 1, 2015, 00:00

  • The Cost-Effectiveness of Dabigatran Etexilate Compared With Edoxaban In The Treatment of Acute Venous Thromboembolism In The Uk

    May 1, 2015, 00:00

  • Analysis of Medicines centrally authorised by the European Medicines Agency (EMA) in the context of their reimbursement in Poland

    May 1, 2015, 00:00

  • Measurement Properties of the patient-reported Psoriasis Symptom inventory daily diary in patients with moderate to severe Plaque Psoriasis

    May 1, 2015, 00:00

  • Geographic variation in depression diagnosis among medicare beneficiaries with acute Myocardial Infarction

    May 1, 2015, 00:00

  • Temporal Trend In Use Of Permanent Female Sterilization Procedures And Characteristics Of Women Who Undergo Them In A Commercially-Insured Population In The U.S

    May 1, 2015, 00:00

  • Cost Effectiveness of Drugs for Pulmonary Arterial Hypertension- A Canadian Study

    May 1, 2015, 00:00

  • What Is The Cost-Effective Bearing Surface Choice In Primary Total Hip Arthroplasty

    May 1, 2015, 00:00

  • Effectiveness of Pharmacotherapy in children with symptomatic epilepsy

    May 1, 2015, 00:00

  • Cost-Effectiveness Of Multiplexed Predictive Biomarker Screening In Non-Small Cell Lung Cancer

    May 1, 2015, 00:00

  • Analysis of Medical costs of rrms Relapses

    May 1, 2015, 00:00

  • Economic Value Of Improved Accuracy For Self-Monitoring Of Blood Glucose Devices For Type 1 Diabetes

    May 1, 2015, 00:00

  • Productivity Growth in California Hospitals from 2005 through 2011

    May 1, 2015, 00:00

  • Cost effectiveness of left atrial appendage closure versus Warfarin for stroke risk reduction in non-valvular Atrial Fibrillation in CMS patients

    May 1, 2015, 00:00

  • Trends in Health Technology Assessment (HTA) recommendations from the UK and Germany – a comparison of G-BA, SMC and NICE single Technology appraisal decisions

    May 1, 2015, 00:00

  • Traditional Medicine use and its impact on antiretroviral Therapy Adherence Among Hiv Patients In Ethiopia

    May 1, 2015, 00:00

  • The Impact Of Race On The Association Between A Novel Genotype-Guided Personalized Warfarin Service And Clinical Outcomes In An Ethnically Diverse Population

    May 1, 2015, 00:00

  • Antipsychotic Medication use Measures for children and adolescents- Metabolic Screening for children on antipsychotics

    May 1, 2015, 00:00

  • Methodology Using Pharmacy And Medical Claims Data To Evaluate Real-World Outcomes And Costs Of Ivf Treatment In The Us

    May 1, 2015, 00:00

  • A Cost-effectiveness analysis of biomarker testing to target treatment to patients with mild cognitive impairment at increased risk of Alzheimer’s Disease

    May 1, 2015, 00:00

  • Cost-Effectiveness Analysis And Budget Impact Of Concor® Am Versus Bisoprolol Plus Amlodipine In Systemic Arterial Hypertension Treatment, From The Perspective Of The Brazilian Public Health System

    May 1, 2015, 00:00

  • Ursodeoxycholic and Chenodeoxycholic Acid Exert Distinct Cytotoxic effects On Colon Cancer cells

    May 1, 2015, 00:00

  • When can pharmaceutical companies communicate health economic claims to payers? 10 case studies

    May 1, 2015, 00:00

  • Patients’ Experiences With Mycosis Fungoides/Sézary Syndrome - Cutaneous T-Cell Lymphoma (Mf/Ss-Ctcl)- Evidence From Qualitative Research Of A Patient Reported Outcome (Pro) Measure Developed On An Online Research Platform

    May 1, 2015, 00:00

  • Measuring Spending Trends For Those With Employer-Sponsored Insurance Using Administrative Data

    May 1, 2015, 00:00

  • Patient Versus General Population Preferences In Anticoagulant Therapy

    May 1, 2015, 00:00

  • Urinary Tract Infection Among the sglt 2 Inhibitors- a Meta-Analysis of 19 Randomized controlled trials

    May 1, 2015, 00:00

  • Treatment Effects On The Cost Burden Of Hospitalizations In Patients With Chronic Systolic Heart Failure

    May 1, 2015, 00:00

  • Evaluation of Patient Reported outcomes (Pro) In Obese Patients In an acute Bacterial skin and skin Structure Infections (Absssi) Phase 3 trial

    May 1, 2015, 00:00

  • Clinical comparison of full course intravenous or abbreviated oral antibiotics in hospitalized patients with methicillin-resistant s. Aureus (mrsa) skin and soft tissue infections

    May 1, 2015, 00:00

  • Epidemiology And Treatment Of Radioactive Iodine-Refractory Differentiated Thyroid Cancer In The Eu5

    May 1, 2015, 00:00

  • Adopting Software Engineering Best Practices In The Field Of Pharmacoeconomics Can Increase The Transparency Of And Confidence In Our Health Economic Models

    May 1, 2015, 00:00

  • Practical problems of comparator selection to assess cost-effectiveness of New Drugs for reimbursement decision- a qualitative study in South Korea

    May 1, 2015, 00:00

  • When is Health Economics and outcomes research evidence important to U.S. payers?

    May 1, 2015, 00:00

  • The effect of DRG-based performance- volume limit on the annual budget of the Clinical Centre of University of Pécs in Hungary

    May 1, 2015, 00:00

  • A Systematic Review Of The Methodological Quality Of Network Meta-Analyses

    May 1, 2015, 00:00

  • Comparison Of Apixaban, Dabigatran, Rivaroxaban, And Edoxaban In The Acute Treatment And Prevention Of Venous Thromboembolism- Systematic Review And Network Meta-Analysis

    May 1, 2015, 00:00

  • Implications Of Employer Coverage Of Contraception- Cost-Effectiveness Of Contraception Under An Employer Mandate

    May 1, 2015, 00:00

  • Infiltration of Liposomal Bupivacaine (LB) Decreases Length of Hospitalization Following Total Knee Arthroplasty (TKA)

    May 1, 2015, 00:00

  • Characteristics of Drug Therapy problems and response rate in Telephonic comprehensive medication reviews provided to 2014 medicare part D Beneficiaries

    May 1, 2015, 00:00

  • Treatment Modifications and Costs of Biologic Therapy In Patients With Ankylosing Spondylitis

    May 1, 2015, 00:00

  • A System dynamics model for the cost-effectiveness Evaluation of Bacterial whole-genome sequencing for monitoring outbreaks of clostridium difficile

    May 1, 2015, 00:00

  • Calculating the costs of adverse Drug Reactions From Post-Marketing Data- Implications for outcomes Research

    May 1, 2015, 00:00

  • Anidulafungin in Comparison to Fluconazole, Amphotericin B Deoxycholate, Amphotericin b Liposomal, Caspofungin And Micafungin For The Treatment of Invasive Candidiasis Among Non-Neutropenicpatients Above 16 Years- Bayesian Mixed Treatment C ...

    May 1, 2015, 00:00

  • Cost burden analysis of relapse in prescription Opioid Drug dependent Patients treated with Buprenorphine/Naloxone and Patients without Pharmacological treatment

    May 1, 2015, 00:00

  • Pharmacoepidemiology of Clostridial collagenase ointment for the Treatment of Diabetic foot Ulcers In Outpatient Care Settings

    May 1, 2015, 00:00

  • Assessing the Generosity of Drug coverage in the Health Insurance Exchanges

    May 1, 2015, 00:00

  • The Economic Value of Tofacitinib 5 Mg Bid In The Treatment of Moderate To Severe Rheumatoid Arthritis- A Canadian Analysis

    May 1, 2015, 00:00

  • Financial impacts of using Omeprazole oral suspension for preventing upper Gastrointestinal bleeding early after Intensive Care admission

    May 1, 2015, 00:00

  • Health care cost burden and demographic distribution of patients diagnosed with psoriatic arthritis in the u.s. Medicare population

    May 1, 2015, 00:00

  • A Comparison Of State Transition And Discrete Event Modeling Approaches For Antiplatelet Use In The Secondary Prevention Of Thrombotic Events After Myocardial Infarction (MI)

    May 1, 2015, 00:00

  • Hierarchy of clinical endpoints in HTA decision making in Oncology

    May 1, 2015, 00:00

  • The burden of Treatment Switch in patients with Major Depression- a us retrospective Admnistrative claims analysis

    May 1, 2015, 00:00

  • Effect of A Tier Change Policy for Biologic Disease Modifying Antirheumatic Drugs (Dmards) On Health Care Cost and Medication Effectiveness

    May 1, 2015, 00:00

  • Cost-Effectiveness Analysis of a Partially Effective Hiv Vaccine In San Francisco

    May 1, 2015, 00:00

  • Knowledge and practice of Pharmacy Students regarding the use of skin whitening product

    May 1, 2015, 00:00

  • Low treatment satisfaction associated with acromegaly in the united states

    May 1, 2015, 00:00

  • Blood Loss And Economic Burden Components of Spinal Fusion Surgery In Adolescent Scoliosis And Adult Deformity

    May 1, 2015, 00:00

  • The Use of Advanced Reporting Integrating Big Data (Corereports)- The Case of osteoporosis

    May 1, 2015, 00:00

  • Estimating the Cost-Effectiveness of Daclatasvir Regimens for Patients With advanced Chronic Hepatitis C in the UK

    May 1, 2015, 00:00

  • Evauation of Corcordance Between Patient Reported Outcomes (Pros) and Clinician Reported outcomes (Cros) In Patients With Metastatic Brain Disease

    May 1, 2015, 00:00

  • Battling fear- a potential key to improving Colorectal Cancer Screening

    May 1, 2015, 00:00

  • Measuring function in cognitive impairment- a suggested taxonomy for characterizing assessment instruments

    May 1, 2015, 00:00

  • How does a small or medium sized pharmaceutical company prepare for and navigate the scottish market?

    May 1, 2015, 00:00

  • Effect of Weight Loss (WL) on Concomitant Medication Costs in Obese/Overweight individuals with Metabolic Syndrome (METS) receiving Phentermine/Topiramate extended-release (PHEN/TPM ER)

    May 1, 2015, 00:00

  • Costs and Challenges Associated with Diagnosis and Treatment of Infections In Hospitalized Patients- A Retrospective us Electronic Health Database Study

    May 1, 2015, 00:00

  • Benefits of patient-reported outcomes in Dermatology Drug Development

    May 1, 2015, 00:00

  • Utilization of Colorectal Screening by medicare beneficiaries in years 2009 and 2011- a cross-sectional study

    May 1, 2015, 00:00

  • Payers’ views on Heterogeneity of treatment effect in Oncology

    May 1, 2015, 00:00

  • Physicians’ Views On Pharma Role In Real World Evidence Generation In Poland

    May 1, 2015, 00:00

  • Indirect Costs Among Metastatic Breast Cancer Patients Receiving Eribulin

    May 1, 2015, 00:00

  • Burden of disease of Hepatitis C in Colombia

    May 1, 2015, 00:00

  • Concerns on who guidelines of Treating and preventing HIV Infection

    May 1, 2015, 00:00

  • Impact of sample collection method for EGFR mutation testing- results of Blood-based and Tissue-based Cobasâ® EGFR mutation testing in the treatment of locally advanced or metastatic NSCLC in the US

    May 1, 2015, 00:00

  • Trends in the use of cost-minimization analysis in Economic Assessments submitted to the SMC

    May 1, 2015, 00:00

  • Budget Impact of Chosing Rebif® as the Interferon of Choice for the Treatment of Relapsing-Remitting Multiple Sclerosis In the Brazilin Public Healthcare System

    May 1, 2015, 00:00

  • Cost-Effectiveness (Ce) Analysis of Empagliflozin 25mg Versus Sitagliptin 100mg in the Treatment of Patients with type 2 Diabetes Mellitus (T2dm) when added to metformin (Met) from a Mexican Public Institutional Context

    May 1, 2015, 00:00

  • Big Data In Emergency Department Care Delivery- Benefits Of Radio Frequency Identification

    May 1, 2015, 00:00

  • Introduction For The Latest Development Of Chinese Pediatric Medicine

    May 1, 2015, 00:00

  • Encouraging orphan designation for new ebola treatments – could this do more harm than good?

    May 1, 2015, 00:00

  • Shared decision making does not improve adherence to Prostate Cancer Screening- evidence from the Health Information National Trend Survey

    May 1, 2015, 00:00

  • Influence of Demographic Status on Outcomes In Copd Patients- A Prospective Study

    May 1, 2015, 00:00

  • Venous Thromboembolism Treatment Patterns In The European Union (Eu) Region- 2013 Retrospective Chart Extraction

    May 1, 2015, 00:00

  • Pharmacoepidemiology of Clostridial collagenase ointment for the treatment of Venous Leg Ulcers In outpatient Care Settings

    May 1, 2015, 00:00

  • High Dose Vancomycin Loading Versus Low Dose is Associated With Decreased Nephrotoxicity In Emergency Department Sepsis Patients

    May 1, 2015, 00:00

  • Qt Prolongation Identification In Retrospective Studies

    May 1, 2015, 00:00

  • Development And Validation Of The Hemophilia-Specific Burden Scale For Caregivers Of Children With Hemophilia In The Us – The Hemophilia Associated Caregiver Burden Scale (Hemocabtm)

    May 1, 2015, 00:00

  • Long-Term Economic Burden Associated With Cardiovascular Events Among High-Risk Patients With Hyperlipidemia

    May 1, 2015, 00:00

  • Idelalisib Plus Rituximab Versus Placebo Plus Rituximab For Relapsed Chronic Lymphocytic Leukemia- A Cost-Effectiveness Analysis

    May 1, 2015, 00:00

  • ISPOR 20th Annual International Meeting Research Abstracts Author Index

    May 1, 2015, 00:00

  • Methods And Context For The Production Of Rapid Reviews

    May 1, 2015, 00:00

  • Audit of irreversible Monoamine Oxidase Inhibitors (MAOI) prescription for depression in current Clinical practice within the Health improvement Network (THIN) UK primary care database

    May 1, 2015, 00:00

  • Budget Impact Analysis of The Inclusion of Tofacitinib In The Public List of Reimbursement In The Treatment of Rheumatoid Arthritis After Inadequate Response To Methotrexate In Colombia

    May 1, 2015, 00:00

  • Hospitalization Costs For Patients With Heart Failure Using Claims Database €“ A Comparison Between Commercial And Medicare Advantage Population

    May 1, 2015, 00:00

  • Orphan drug designation- a comparison of Policies, processes and results from the US and the EU

    May 1, 2015, 00:00

  • Estimating the value of Whole Exome Sequencing for parents of Children with Rare Genetic Diseases

    May 1, 2015, 00:00

  • Cost-effectiveness of a Behavioral Psychosocial treatment integrated across Home and School for Pediatric ADHD-Inattentive type

    May 1, 2015, 00:00

  • Two-Part Pricing For Patent Protected Medicines †“An Economic Analysis From A Swedish Health Care Perspective

    May 1, 2015, 00:00

  • Economic burden of Colorectal Cancer in Vietnam- from Healthcare payers’ perspective

    May 1, 2015, 00:00

  • The availability and Expenditure of Orphan Medicines in Poland

    May 1, 2015, 00:00

  • The cost-effectiveness of Drug-Eluting stents versus bare Metal stents in Taiwan

    May 1, 2015, 00:00

  • Patterns of Psychotropic prescription Utilization among disabled Medicare Beneficiaries Under 65

    May 1, 2015, 00:00

  • Knowledge Gaps About Pneumonia in older Adults- Baseline Results from the Pharmacists’ Pneumonia Prevention Project

    May 1, 2015, 00:00

  • Antipsychotic Utilization among Washington State dual Eligibles

    May 1, 2015, 00:00

  • Racial/Ethnic disparities in Disability Prevalence

    May 1, 2015, 00:00

  • Gender differences in the use of Complementary and Alternative Medicine among Adults with Multiple Chronic conditions

    May 1, 2015, 00:00

  • Low-Molecular-Weight Heparin Treatment Of Deep-Vein Thrombosis- A Network Meta-Analysis

    May 1, 2015, 00:00

  • Generic competition and Authorized Generics in the United States

    May 1, 2015, 00:00

  • Cost analyses of Lutonix® 035 DCB PTA catheters for the treatment of Femoropopliteal Artery Stenosis- A U.S. Hospital perspective

    May 1, 2015, 00:00

  • Changes of the Hungarian Health Insurance Pharmaceutical Budget between 2007-2013

    May 1, 2015, 00:00

  • Medication Utilization Pattern for pain Management among Individuals with type 2 Diabetes

    May 1, 2015, 00:00

  • Health Related Quality Of Life In Patients Using Complementary Alternative Medicine (Homeopathy) In Quetta, Pakistan

    May 1, 2015, 00:00

  • Advancing Methods Of Hta- Optimising Monitoring Tests To Meet Value Targets

    May 1, 2015, 00:00

  • Projecting Changes in total days of therapy (DOT) In Patients Hospitalized for Acute Bacterial Skin and Skin Structure Infection (Absssi)

    May 1, 2015, 00:00

  • Second prospective, Pharmacoepidemiologic database analysis of Phentermine and Topiramate extended-release usage from a representative us sample of Older Patients

    May 1, 2015, 00:00

  • The validity of Algorithms for identifying suspected and confirmed Heparin-induced Thrombocytopenia

    May 1, 2015, 00:00

  • Economic Implications Of Increased Utilization Of 5% Albumin For Fluid Resuscitation Post On-Pump Cardiac Procedures In Us Hospitals

    May 1, 2015, 00:00

  • Growth Hormone deficiency in Pediatrics- Concept Elicitation To Support The Development of Child Pro And Parent Obsro Measures

    May 1, 2015, 00:00

  • Impact of a Pharmacist telephone intervention on medication adherence among Hypertensive Patients with diabetes in a medicare advantage plan

    May 1, 2015, 00:00

  • Cost effectiveness of Sacral Neurostimulation for overactive bladder in Mexico

    May 1, 2015, 00:00

  • Engaging Patients With E-Clinical Technology- Incorporating Patient Preferences Into Diabetes Clinical Trials And Care

    May 1, 2015, 00:00

  • Cost-effectiveness of interferon-free Therapy for Hepatitis C in Germany - an application of the efficiency frontier approach

    May 1, 2015, 00:00

  • Measuring Risk Factors for Non-Adherence Using Patient-Reported Outcomes In Studies Evaluating Adherence With Oral Antineoplastic Agents- A 10-Year Review

    May 1, 2015, 00:00

  • Hemostasis efficacy of evarresttm compared to Tachosil® in Liver and other Surgical Bleeding- an indirect comparison

    May 1, 2015, 00:00

  • Paroxetine use and Cognition in elderly nursing Home Patients with Depression

    May 1, 2015, 00:00

  • Competition and strategic regulation in the Argentine Pharmaceutical Market. a comparative study of six Therapeutic classes

    May 1, 2015, 00:00

  • Comparing the predictive performance of two variants of the elixhauser comorbidity measures for all-cause in-hospital mortality in a large multi-payer u.s. Administrative database

    May 1, 2015, 00:00

  • Cost-Effectiveness of Primary Prophylaxis With Pegfilgrastim Vs Lipegfilgrastim To Reduce The Incidence of Febrile Neutropenia In Patients With Early Stage Breast Cancer or Non-Hodgkin Lymphoma

    May 1, 2015, 00:00

  • Statistical Identification Of Patient Selection Bias In Retrospective Chart Reviews

    May 1, 2015, 00:00

  • Potential savings from a 15-day initial fill Policy for selected outpatient Medications in a State Medicaid Program

    May 1, 2015, 00:00

  • Cost-Efficacy Analysis Of Ipilumumab In Peru

    May 1, 2015, 00:00

  • Utilities for Health States In Patients With Relapsed/Refractory Non-Hodgkin Lymphoma And Factors Influending Utility Values

    May 1, 2015, 00:00

  • Long term follow up of Primary and Secondary prevention implantable cardioverter defibrillator patients- “Real-World” data from the Island of crete

    May 1, 2015, 00:00

  • Adherence to Chronic Obstructive Pulmonary Disease Maintenance Medication Among Patients With Copd

    May 1, 2015, 00:00

  • Out-of-Pocket Expenses for Copd Patients In A Third Level Hospital

    May 1, 2015, 00:00

  • Cost of Treatment of Radiopharmaceutical and Chemotherapy for the Treatment of Castration-Resistant Prostate Cancer With Bone Metastases In Hospital Setting

    May 1, 2015, 00:00

  • Incremental burden of group 3 Pulmonary Hypertension patients to U.S. payer

    May 1, 2015, 00:00

  • Economic outcomes among medicare patients receiving skin substitutes for treatment of Diabetic foot Ulcers

    May 1, 2015, 00:00

  • Cost-utility of Vortioxetine versus Venlafaxine xr in the treatment of Major depressive Disorder in South Korea

    May 1, 2015, 00:00

  • Assessment Of Medication Adherence Among Patients With Non-Communicable Chronic Diseases In Quetta Baluchistan, Pakistan

    May 1, 2015, 00:00

  • Priority Access for the Biggest – Variable Provincial Access to Oncology Drugs In Canada

    May 1, 2015, 00:00

  • An intensive study of adverse events in the Medical Unit of a Nigerian Teaching Hospital

    May 1, 2015, 00:00

  • Managed care Organization Budget impact of adding Recombinant Factor VIII FC fusion protein (RFVIIIFC) to the formulary for the treatment of Hemophilia A

    May 1, 2015, 00:00

  • Substance use admissions trend among Older Adults

    May 1, 2015, 00:00

  • Using Fact Data to Predict Preference-Based Utility Measures For People With Malignant Melanoma- A Review of The Evidence

    May 1, 2015, 00:00

  • Clinical Effect and Therapeutic Drug Monitoring of Vancomycin Treatment on Neonatal Bacterial Sepsis

    May 1, 2015, 00:00

  • Prevalence And Losses In Quality-Adjusted Life Years Of Child Health Conditions- A Burden Of Disease Analysis

    May 1, 2015, 00:00

  • Compare Early Mortality After Aortic Valve Replacement With Mechanical Prosthetic Vs Bioprosthetic Valves Among Medicare Beneficiaries

    May 1, 2015, 00:00

  • A Retrospective Database Study To Investigate The Morbidity And Pharmaceutical Intervention Of Pulmonary Arterial Hypertension In Japan

    May 1, 2015, 00:00

  • Impact of Clinical and Health Economic Publications on Commercial success of Pharmaceutical products in the U.S

    May 1, 2015, 00:00

  • Inclusion Of Multiple Studies In Matching Adjusted Indirect Comparisons (Maic)

    May 1, 2015, 00:00

  • Key trends in Healthcare spending in Brazil in 2015

    May 1, 2015, 00:00

  • In their own words- Social listening for “Real-World Benefits” from prescription and OTC products

    May 1, 2015, 00:00

  • Can a web-based tool to facilitate communication between patient and healthcare providers improve patient-reported outcomes?

    May 1, 2015, 00:00

  • The impact of increasing severity of Hereditary Haemochromatosis on Health State Utility values

    May 1, 2015, 00:00

  • Gender Disparities In Migraine Pharmacotherapy- Application Of Propensity Score-Matched Analyses

    May 1, 2015, 00:00

  • The Country Archetype Model- Unlocking The Door To Global Market Access

    May 1, 2015, 00:00

  • Risk of Cardiovascular events Associated with Necessary Interventions for Parkinson Disease

    May 1, 2015, 00:00

  • Research Presentations Financial Disclosure Statements

    May 1, 2015, 00:00

  • Use Of Work Productivity Endpoints In Clinical Studies- A Review By Disease State And Measurement Type

    May 1, 2015, 00:00

  • Age and Gender distribution of outpatient care Physiotherapy services for Shoulder and Upper Arm Injuries in Hungary

    May 1, 2015, 00:00

  • Promoting market access through breakthrough therapy designation- can this accolade help convince payers and prescribers?

    May 1, 2015, 00:00

  • Burden of Melanoma among adults enrolled in medicaid program

    May 1, 2015, 00:00

  • Meta-Analysis of Efficacy and Safety of Denosumab In Postmenopausal Osteoporosis

    May 1, 2015, 00:00

  • Use of low-cost Generic Programs in a Nationally representative Medicare Population and implications for Quality initiatives

    May 1, 2015, 00:00

  • Is spatial segregation by income associated with self-reported disability in chile? Exploratory analysis using a population-based survey

    May 1, 2015, 00:00

  • Pharmacoeconomics Research On Diabetes And Hypertension In India- A Study Based On Pubmed Database

    May 1, 2015, 00:00

  • Health care Resource Utilization Before and after natalizumab Initiation among multiple Sclerosis Patients in Germany

    May 1, 2015, 00:00

  • The difference between the maximum retail Price and tender Pri a comparative study on Brandname and Generic Drugs

    May 1, 2015, 00:00

  • Persistence With First-Line Biologics Used In Rheumatoid Arthritis In a us Managed Care Population

    May 1, 2015, 00:00

  • Comparative Effectiveness Of Angiotensin Converting Enzyme Inhibitors And Angiotensin Ii Receptor Blockers In Heart Failure

    May 1, 2015, 00:00

  • Predicting Medication Adherence And Healthcare Costs In A Managed Care Population

    May 1, 2015, 00:00

  • Impact of Rheumatoid Arthritis on Self-Reported Work Productivity, Disease Severity And Adherence In an Employed Population

    May 1, 2015, 00:00

  • Use of Oritavancin for the Treatment of Skin and soft Tissue Infections- A Uk Hospital Budget Impact Analysis

    May 1, 2015, 00:00

  • Participation In Cervical Cancer Screening And Knowledge On Human Papillomavirus Among Women In Vác, Hungary

    May 1, 2015, 00:00

  • Treatment patterns of Endocrine Therapy and Chemotherapy among post-menopausal Women with HR+/HER2- metastatic Breast Cancer

    May 1, 2015, 00:00

  • Cost-Effectiveness Evaluation Of Genotype-Guided Antiplatelet Therapy Versus Universal New Antiplatelet Therapy In Patients With Acute Coronary Syndrome

    May 1, 2015, 00:00

  • Assessment of The Quality of Life In Chinese Myasthenia Gravis Patients

    May 1, 2015, 00:00

  • A Comprehensive Survey Of Managed Care Organization (Mco) Medication Adherence Intervention Programs

    May 1, 2015, 00:00

  • Real-World Data Utility For Health Economic Modeling- An Assessment Of Current Data Sources

    May 1, 2015, 00:00

  • Systematic Review of Epidemiology And Burden of Cutaneous T-Cell Lymphoma

    May 1, 2015, 00:00

  • Predictors of Mammography screening among Women aged 50-74

    May 1, 2015, 00:00

  • Impact Of Weight-Related Utilities On The Cost-Effectiveness Of Canagliflozin (Cana) Versus Sitagliptin (Sita) As Third-Line Therapy In Type 2 Diabetes Mellitus (T2dm) In A Canadian Setting

    May 1, 2015, 00:00

  • Serious adverse Drug events reported to the Food and Drug Administration (FDA)- analysis of the FDA adverse event reporting system (FAERS) 2006-2011 database

    May 1, 2015, 00:00

  • Quality of Care for childhood attention deficit/hyperactivity disorder- a Retrospective analysis of mississippi medicaid program

    May 1, 2015, 00:00

  • Direct costs of Healthcare of multiple Sclerosis, the case of a Health manteinance Organization in Colombia

    May 1, 2015, 00:00

  • Measuring Adherence and outcome in Treatment of Multiple Sclerosis In the Geisinger Clinic

    May 1, 2015, 00:00

  • Data Cleaning Paper Patient Reported Outcome (PRO) Data Versus Electronic Patient Reported Outcome (EPRO) Data

    May 1, 2015, 00:00

  • Lung Cancer Economic Burden From a Private Healthcare System Perspective In Brazil

    May 1, 2015, 00:00

  • Drivers of Healthcare resource Utilization and factors associated with increased resource use in Patients with Fibromyalgia- an evaluation using Electronic Medical Records

    May 1, 2015, 00:00

  • Antipsychotics Treatment and Quality of Life in Schizophrenia Patients

    May 1, 2015, 00:00

  • Drivers and Behaviors of Adults who received vaccination at different Settings

    May 1, 2015, 00:00

  • Examination of interval incidence of Colorectal Cancer (CRC) at subsequent colonoscopy over time- population-based retrospective cohort study

    May 1, 2015, 00:00

  • Cost-Effectiveness Of Cyp2d6 Genotyping In Older Depressed Patients, Starting With Nortriptyline Therapy

    May 1, 2015, 00:00

  • Assessing the Quality of Health Economic Evaluations Published in Japanese settigns- a systematic review of 1991-2012 Literature

    May 1, 2015, 00:00

  • The Effect Of Cost-Related Medication Nonadherence On The Decision Of Taking Up Medicare Part D Among Elderly Medicare Beneficiaries

    May 1, 2015, 00:00

  • Is there an Association between potentially inappropriate prescribing in the elderly and Hospitalization and Mortality? a Longitudinal, large Cohort study

    May 1, 2015, 00:00

  • Project Skant - Study of Antibiotic Prescription In Community In Slovakia

    May 1, 2015, 00:00

  • Prevalence and burden of Ankle injuries in North Carolina emergency departments

    May 1, 2015, 00:00

  • Self-Medication and Associated Health Care Costs- A Survey In The Urban And Rural Population of A Major City In Pakistan

    May 1, 2015, 00:00

  • Are Generic Medicines Good for my patients? findings from a qualitative assessment of perceptions among medical specialists in Malaysia

    May 1, 2015, 00:00

  • Health-Related Quality Of Life Among Esrf Patients In Pakistan- A Cross-Sectional Approach Using Whoqol-Bref

    May 1, 2015, 00:00

  • Resource Utilization and costs associated with multi-drug Resistant acinetobacter Baumannii- a Systematic Review of The Literature

    May 1, 2015, 00:00

  • Use of Attention-Deficit/Hyperactivity Disorder (ADHD) Drugs in Canada, 2010-2014

    May 1, 2015, 00:00

  • Medication Utilization in incident adverse Drug reactions of Cancer Chemotherapy - a Pharmacist Perspective

    May 1, 2015, 00:00

  • Analysis of Purchase of Antibacterial Drugs Within the Guaranteed Volume of Free medical aid In The Republic of Kazakhstan

    May 1, 2015, 00:00

  • The Budget Impact of Treatment Pathway Redesign In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (Bph)

    May 1, 2015, 00:00

  • The Costs of Cancer-Related Absenteeism- a Systematic Review of The Literature

    May 1, 2015, 00:00

  • Usability Testing Of The Web-Based Versions Of The Standardised Asthma Quality Of Life Questionnaire For 12 Years And Older (Aqlq(S)+12) And The Asthma Control Questionnaire (Acq-6)

    May 1, 2015, 00:00

  • Mipomersen For Treatment Of Hypercholesteremia- Evidence Review And Meta Analytic Evaluation Of Randomized Controlled Trials

    May 1, 2015, 00:00

  • Examining the budget impact of adopting netupitant/palonosetron for the prevention of chemotherapy induced nausea and vomiting in a u.s. Health plan

    May 1, 2015, 00:00

  • Pharmacoepidemiology of Clostridial collagenase ointment for the treatment of Pressure Ulcers In outpatient Care Settings

    May 1, 2015, 00:00

  • Out of Pocket Cost for Pediatric Epilepsy management- results from malaysian population

    May 1, 2015, 00:00

  • Efficacy And Safety Of Amlodipine And Bisoprolol In Hypertension Treatment- A Systematic Review

    May 1, 2015, 00:00

  • Cost of Illness, Diagnosis and treatment patterns for Diabetic Macular Edema across 13 Countries

    May 1, 2015, 00:00

  • Changes in the safety Profile of oral Diabetes Medications approved by the fda

    May 1, 2015, 00:00

  • A Systematic Literature Review of The Cost-Effectiveness of Erythropoietin In Orthopedic Surgery- There Is A Need For Differentiation Between Total Hip And Knee Arthroplasty

    May 1, 2015, 00:00

  • Gender-Specific Differences In Risk for Cost-Related Medication Nonadherence Among Cancer Survivors

    May 1, 2015, 00:00

  • Interferon-Â therapies for the treatment of multiple Sclerosis In Brazil- a Systematic Review with Meta-analysis

    May 1, 2015, 00:00

  • Observational Study of The Outcomes and Costs Of Initiating Inhaled Long-Acting Bronchodilators Versus Inhaled Short-Acting Bronchodilators Therapies In Newly-Diagnosed Copd Patients

    May 1, 2015, 00:00

  • High cost Oncology products demand additional administrative burden on Clinicians in select EMEA Markets

    May 1, 2015, 00:00

  • Explicative Model Of The Health Expenditure For Contributive Health Subsystem Population In Colombia

    May 1, 2015, 00:00

  • A review of the literature regarding biosimilars- what is the evidence for equivalence?

    May 1, 2015, 00:00

  • Influence of Patient-Reported Outcomes on Market Access Decisions In Decentralized Markets (Brazil, Italy, Spain, and the United States)

    May 1, 2015, 00:00

  • Comorbidity Burden And Incremental Cost of Fractures In Medicare Men With Non-Metastatic Prostate Cancer Treated With Androgen Deprivation Therapy

    May 1, 2015, 00:00

  • Using The Clinical Summary Score From The Kansas City Cardiomyopathy Questionnaire As An Endpoint In Clinical Trials- Psychometric Support

    May 1, 2015, 00:00

  • How many Outpatient Surgery beds do we need?

    May 1, 2015, 00:00

  • The Impact Of Parents’ Knowledge And Practice On Their Children Immunization Timeliness- Experience From Malaysia

    May 1, 2015, 00:00

  • Evolution of the Market for oral Antidiabetic agents In Canada after Introduction of Dipeptidyl Peptidase-4 Inhibitors

    May 1, 2015, 00:00

  • Economic analysis of Evarresttm compared with standard care in CHALLENGING Liver Surgical Bleeding Populations- a U.S. Hospital perspective

    May 1, 2015, 00:00

  • Describing Medication Adherence Across A Population- The Value Of Considering Multiple Measures

    May 1, 2015, 00:00

  • Efficiency analysis of the Hungarian outpatient-care system with data envelopment analysis

    May 1, 2015, 00:00

  • Lean Workflow changes may contribute to Improved primary care patient satisfaction

    May 1, 2015, 00:00

  • A Situation Analysis Of Health Policy And Health Technology Assessment In Kazakhstan

    May 1, 2015, 00:00

  • Evaluation of The Annual Cost of Medicines used In treatment of Type 2 diabetes Mellitus In India

    May 1, 2015, 00:00

  • Comparing Diagnosis-Based And Prescription-Based Comorbidity Measures For Predicting Health Service Utilization And Costs

    May 1, 2015, 00:00

  • Development Of The Hyperphagia Questionnaire For Use In Prader-Willi Syndrome Clinical Trials

    May 1, 2015, 00:00

  • Improvement in Health-related quality of life for Sickle Cell Disease Patients treated with Chemotherapy-Free Allogeneic Hematopoietic Stem-Cell Transplantation- a Pilot Study

    May 1, 2015, 00:00

  • Risks of Fractures in Vitiligo Patients treated with Phototherapy

    May 1, 2015, 00:00

  • What type of response scale is the most responsive? A comprehensive review of response scale options for patient-reported outcome measures

    May 1, 2015, 00:00

  • Self-reported Depression and Prescription of Antidepressants; does Gender Matter?

    May 1, 2015, 00:00

  • Prevalence And Outcomes Of Global Vascular Hospital Admissions In Argentina

    May 1, 2015, 00:00

  • Predictors of a positive Cancer Drug fund decision

    May 1, 2015, 00:00

  • The concentration of Antipsychotic prescribing- Evidence from Medicaid

    May 1, 2015, 00:00

  • A Systematic review and network meta-analysis of anti-Diabetes Treatments for adults with type 2 Diabetes Mellitus Inadequately Controlled on Insulin and Oral anti-Diabetes Drugs

    May 1, 2015, 00:00

  • Relative Efficacy and Tolerability of Vortioxetine compared with selected Antidepressants in patients with Major depressive Disorder with an inadequate response to prior Therapy

    May 1, 2015, 00:00

  • Differences in Mastectomy Rates Based on Hormone Receptor Status in Early Stage Tumors- A Seer Database Analysis

    May 1, 2015, 00:00

  • Depression And Quality Of Life Among Individuals With Chronic Obstructive Pulmonary Disease In North India

    May 1, 2015, 00:00

  • Assessing Knowledge and Attitude about ebola in the US- a Cross Sectional Survey

    May 1, 2015, 00:00

  • Development Of A Database Of Published Regulatory Recommendations Concerning The Use Of Clinical Outcome Assessment (Coas) In Drug Development- Outcomes Insite

    May 1, 2015, 00:00

  • An analysis of NICE recommended in line with Clinical practice Health Technology Assessment decisions

    May 1, 2015, 00:00

  • Patient-reported outcome measures for Multiple Sclerosis Phase Iv Clinical Trials- A Systematic Review

    May 1, 2015, 00:00

  • Annual Incidence Rates of Herpes Zoster among an Immunocompetent Population In The United States

    May 1, 2015, 00:00

  • Economic Benefits of Ultrasonic devices in thyroidectomy

    May 1, 2015, 00:00

  • How are topics selected and prioritized by the national institute of health and care excellence (nice) and what might be the options if a technology is not selected?

    May 1, 2015, 00:00

  • Aprotinin free Hemostatic sealant to reduce Blood loss in Surgical Patients- a systematic review

    May 1, 2015, 00:00

  • Estimating The Cost Of Illness Of Giant Cell Arteritis

    May 1, 2015, 00:00

  • Cost-Effectiveness of Radium-223 Dichloride (Radium-223) In Alsympca- A Cost-Effectiveness Analysis of Radium-223+Best Standard of Care (Bsoc) Compared With Placebo+Bsoc In Treatment of Castration-Resistant Prostate Cancer (Crpc) And Sympto ...

    May 1, 2015, 00:00

  • Analyzing eq-5d in phase 3 clinical trials of type 2 diabetes mellitus (t2dm)- is mean change capturing patient impact?

    May 1, 2015, 00:00

  • Impact Of The Patient Protection And Affordable Care Act Contraceptive Coverage Mandate On Utilization Of Refillable And Long-Acting Reversible Contraceptives

    May 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Ipx066 In advanced Parkinson’s Disease

    May 1, 2015, 00:00

  • The trouble with cost-utility HTA bodies- they should determine the Price not react to it

    May 1, 2015, 00:00

  • Use of Global data sets to assess innovation Landscapes in Emerging Markets

    May 1, 2015, 00:00

  • Cost-Efectiveness Of Dabigatran In Non Valvular Atrial Fibrillation In Colombia

    May 1, 2015, 00:00

  • Choice of Sequential Biological Therapies In Metastatic Colorectal Cancer (Mcrc)- a Cost Comparison Analysis For Wild-Type Kras Mcrc Patients In Brazil

    May 1, 2015, 00:00

  • Contrasting The Relative Risk Reduction Of Cardiovascular Events In The Core Diabetes Model Associated With Single Risk Factor Changes Across Alternative Risk Engines- Ukpds68, Ukpds82 And Swedish National Diabetes Registry Equations

    May 1, 2015, 00:00

  • LIFETIME HEALTH CARE COSTS OF OBESITY-RELATED COMORBIDITIES IN THE UNITED STATES, 2007-2010

    May 1, 2015, 00:00

  • Real-world canagliflozin utilization- Impact on glycemic control in Patients with Type 2 diabetes mellitus

    May 1, 2015, 00:00

  • Bariatric Surgery in the Brazilian Health Care System- resources Utilization

    May 1, 2015, 00:00
  • «
  • 91
  • 92
  • 93
  • 94 (current)
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • »